type-2-diabetes-mellitus

Documents about type-2-diabetes-mellitus

• The Impact of Ursodeoxycholic Acid and Probiotics on Metabolic Outcomes in Type 2 Diabetic Patients Taking Metformin#261487ClinicalTrials.gov
• Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes#123634ClinicalTrials.gov
• A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in The Netherlands, as Part of Local Clinical Practice#195478ClinicalTrials.gov
• Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)#238309ClinicalTrials.gov
• A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in France, as Part of Local Clinical Practice (SURE FRANCE)#267966ClinicalTrials.gov
• Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles.#272298ClinicalTrials.gov
• A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)#127815ClinicalTrials.gov
• Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)#123432ClinicalTrials.gov
• Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes#238300ClinicalTrials.gov
• The Efficacy of Insulin Degludec/Liraglutide as add-on Therapy in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on Sulphonylurea With or Without Metformin Therapy#143802ClinicalTrials.gov
• Comparing Efficacy and Safety of Insulin Detemir Plus Insulin Aspart and NPH Insulin Plus Human Soluble Insulin With or Without Metformin in Chinese Patients With Type 2 Diabetes#162363ClinicalTrials.gov
• Pilot Bioequivalence Study of Chiglitazar/Metformin Extended-Release Tablets#28588ClinicalTrials.gov
• Low Dose Fat-Induced Insulin Resistance#67799ClinicalTrials.gov
• Metformin Usage Index and Vitamin B12 Status in Egyptian Type 2 Diabetic Patients#67828ClinicalTrials.gov
• A Study of Glycemic Control in Left Ventricular Assist#123649ClinicalTrials.gov
• GLP-1 and Non-exercise Activity Thermogenesis in RHZ#140950ClinicalTrials.gov
• Compliance of Diabetic Patients Treated With Metformin#140964ClinicalTrials.gov
• Empagliflozin-based Quadruple Therapy vs Basal Insulin-based Therapy#146419ClinicalTrials.gov
• Predictive Markers of Glitazone Efficacy in Diabetic Patients - Pilot Study#160324ClinicalTrials.gov
• Effects of Dietary Supplement Tauroursodeoxycholic Acid on Vascular Function#181702ClinicalTrials.gov
• First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050#181708ClinicalTrials.gov
• Personalized Glucose Optimization Through Nutritional Intervention#195502ClinicalTrials.gov
• Bioequivalence Study of Saxagliptin and Glucophage Combination Formulations in Healthy Subjects (A)#216977ClinicalTrials.gov
• Computerized Cognitive Training for Diabetic Elderly Veterans#230349ClinicalTrials.gov
• Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular Dysfunction#234386ClinicalTrials.gov
• Avandia™ + Amaryl™ or Avandamet™ Compared With Metformin (AVALANCHE™ Study)#252946ClinicalTrials.gov
• HELICOBACTER PYLORI INFECTION IN TYPE 2 DIABETES MELLITUS IN ASSIUT UNIVERSITY HOSPITAL#267963ClinicalTrials.gov
• Continuation of Metformin to Improve And Keep Peri-operative Glycemic Control#267967ClinicalTrials.gov
• Investigation for Health Efficacy of Infrared-C Radiation on Diabetes Patients in Senior's Activity Center#154833ClinicalTrials.gov
• Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes#181672ClinicalTrials.gov
• Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness#184761ClinicalTrials.gov
• Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment#234567ClinicalTrials.gov
• Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers#261483ClinicalTrials.gov
• Plasma proteome profiling identifies XPNPEP3 as a novel biomarker associated with metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus#120093Europe PMC
• Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)#67841ClinicalTrials.gov
• A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.#126064ClinicalTrials.gov
• A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)#127808ClinicalTrials.gov
• Health Outcomes of Patients With Type 2 Diabetes Treated With Dapagliflozin in Conjunction With Insulin#257006ClinicalTrials.gov
• Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes#272316ClinicalTrials.gov
• Study to Identify Adequate Biomarker to Detect Vitamin B12 Deficiency in Type 2 Diabetic Patients Treated With Metformin#245455ClinicalTrials.gov
• Lifestyle interventions to prevent gestational and type 2 diabetes among migrant women from low- and middle-income countries: a systematic review.#29693PubMed
• MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)#162405ClinicalTrials.gov
• Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes#28550ClinicalTrials.gov
• Diabetes Effects on Long-Term Implant Survival and Success#126006ClinicalTrials.gov
• To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.#127761ClinicalTrials.gov
• Health Mindset as a Driver of Efficacy of a Diabetes Prevention Program in the Blackfeet Community#208346ClinicalTrials.gov
• A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before#140961ClinicalTrials.gov
• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease#143713ClinicalTrials.gov
• The Effects of Glucose Control and Weight Loss Between Beinaglutide and Dulaglutide in Type 2 Diabetes With Overweight or Obesity.#162361ClinicalTrials.gov
• Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes#195512ClinicalTrials.gov